Related Experiment Videos

Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment

L Scarpioni¹, S Ballocchi, R Scarpioni

¹Divisione di Nefrologia e Dialisi, Ospedale Civile, Piacenza, Italy.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis

|January 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Dialysis-related amyloidosis: challenges and solutions.

International journal of nephrology and renovascular disease·2016

Natural killer cell cytotoxicity is enhanced by very low doses of rIL-2 and rIFN-alpha in patients with renal cell carcinoma.

Medical oncology (Northwood, London, England)·2008

Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER).

Journal of nephrology·2005

A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation.

Transplantation·2000

Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: prospective cross-over study with a three-compartment bag.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis·2000

Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial.

American journal of nephrology·1996

See all related articles